Weight loss could be just a pill away, study of new medication suggests
An oral weight loss pill has performed well in clinical trials, positioning it as a potential alternative to injectable GLP-1 medications like Ozempic and Wegovy.The Eli Lilly drug, called orforglipron, demonstrated "meaningful weight loss" and cardiometabolic improvements, according to a press release.The phase 3 ATTAIN-1 trial, which was published in the New England Journal of Medicine, evaluated the safety and efficacy of the drug in adults who have a weight-related […]